MINIMS CYCLOPENTOLATE HYDROCHLORIDE 1% Eye Drops
Cyclopentolate Hydrochloride 1% Eye prep
10mg/ml
CHAUVIN PHARMACEUTICALS LTD.
| Pack size | 0.5ml Minims x 20 |
|---|---|
| Dispensing mode | POM |
| Source | UK |
| Agent | LUNATUS DRUG STORE |
| Retail Price | 60.50 AED |
Indications
MINIMS CYCLOPENTOLATE HYDROCHLORIDE 1% Eye Drops is used for:
Pediatric eye examinations, Mydriasis, Cycloplegia, Uveitis, Iritis
Adult Dose
Ophthalmic
Mydriasis and cycloplegia for diagnosis
Adult: Instill 1-2 drops into the affected eye/s repeated after 5-15 minutes.
Child Dose
Ophthalmic
Mydriasis and cycloplegia for diagnosis
Child: Instill 1-2 drops of a 1% solution repeated after 5-15 minutes.
Infants ?3 mth: Not recommended.
Renal Dose
Administration
Contra Indications
Children under 3 months of age, Glaucoma, or people with a tendency to glaucoma because of a shallow anterior chamber, Conditions where the gut is not functioning properly, resulting in an obstruction in the bowel (paralytic ileus), Children with organic brain syndromes, including congenital or neuro-developmental abnormalities such as epilepsy.
This medicine should not be used if history of allergies to one or any of its ingredients.
Precautions
This medicine is for use in the eyes only and must not be taken by mouth.
These eye drops can cause blurred vision, difficulty focusing and sensitivity to light. The effects can last for up to 24 hours. You must not drive or take part in hazardous activities unless you can see clearly.
You should not wear soft contact lenses during treatment with these eye drops. This is because they contain a preservative called benzalkonium chloride, which can be absorbed by soft contact lenses and cause eye irritation.
Lactation: Excretion in milk unknown; use with caution
Pregnancy-Lactation
Pregnancy Category: C
Lactation: Excretion in milk unknown; use with caution
Interactions
Plasma concentration may be increased with the use of cimetidine, diltiazem, disulfiram, methylphenidate, ritonavir, and verapamil. Side-effects are increased by adrenaline, amiodarone, general anesthetics, SSRIs, antihistamines, antimuscarinics, antipsychotics, anxiolytics and hypnotics, clozapine, disopyramide, diuretics, flecainide, MAOIs, moclobemide, moxifloxacin, nefopam, nicorandil, noradrenaline, phenothiazine, pimozide, procainamide, propafenone, quinidine, selegiline, sibutramine, sotalol, terfenadine, thioridazine, and tramadol.
Effects of adrenergic neurone blockers, clonidine, barbiturates, nitrates, and primidone are reduced while effects of baclofen, opioid analgesics, and thyroid hormones are enhanced with concomitant use of cyclobenzaprine. Carbamazepine and rifampicin may increase metabolism of cyclobenzaprine. Effects may be antagonized by oestrogens. Avoid use with brimonidine, entacapone, artemether with lumefantrine, or sibutramine. CNS effects may be enhanced by other CNS depressants.
Adverse Effects
Side effects of Cyclopentolate Hydrochloride 1% Eye prep :
Blurred vision, Burning sensation in eye, Light intolerance, Tachycardia, Conjunctivitis, Raised intraocular pressure, Hyperreactive response in Down's syndrome children (atropine), Drowsiness
Mechanism of Action
Cyclopentolate is an anticholinergic. It produces dilatation of the pupil and paralysis of accommodation. Has a shorter duration of action than atropine.
Note
MINIMS CYCLOPENTOLATE HYDROCHLORIDE 1% 10mg/ml Eye Drops manufactured by CHAUVIN PHARMACEUTICALS LTD.. Its generic name is Cyclopentolate Hydrochloride 1% Eye prep. MINIMS CYCLOPENTOLATE HYDROCHLORIDE 1% is availble in United Arab Emirates.
Farmaco UAE drug index information on MINIMS CYCLOPENTOLATE HYDROCHLORIDE 1% Eye Drops is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.